Testing of urinary Escherichia coli isolates for Shiga toxin production

Comment

C M Thorpe et al. Clin Infect Dis. 2001.

. 2001 May 15;32(10):1517-8.

doi: 10.1086/320173.

No abstract available

Comment on

Hemolytic-uremic syndrome following urinary tract infection with enterohemorrhagic Escherichia coli: case report and review.
Starr M, Bennett-Wood V, Bigham AK, de Koning-Ward TF, Bordun AM, Lightfoot D, Bettelheim KA, Jones CL, Robins-Browne RM. Starr M, et al. Clin Infect Dis. 1998 Aug;27(2):310-5. doi: 10.1086/514656. Clin Infect Dis. 1998. PMID: 9709881 Review.
Shiga toxin-producing Escherichia coli urinary tract infection associated with hemolytic-uremic syndrome in an adult and possible adverse effect of ofloxacin therapy.
Miedouge M, Hacini J, Grimont F, Watine J. Miedouge M, et al. Clin Infect Dis. 2000 Feb;30(2):395-6. doi: 10.1086/313668. Clin Infect Dis. 2000. PMID: 10671349 No abstract available.
The low prevalence of shiga-toxin production among sorbitol non-fermenting Escherichia coli urinary tract isolates does not warrant routine screening.
Wilson D, Tuohy M, Procop GW. Wilson D, et al. Clin Infect Dis. 2000 Nov;31(5):1313. doi: 10.1086/317439. Clin Infect Dis. 2000. PMID: 11073778 No abstract available.